“pharmacyclics” Archives

in
Entry Author Date Location
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
Tocagen Appoints Lori Kunkel as Acting Chief Medical Officer 11/16/18 San Diego
MEI Pharma Inks Cancer Drug Deal with Japan’s Kyowa Hakko Kirin 11/05/18 San Diego
Equillium Plans IPO to Fund Clinical Trials for Transplant Drug 09/21/18 San Diego
To Infinity and Beyond: Julian Adams on Missteps and His New Job 04/03/17 Boston
Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug 11/02/16 Boston
In M&A Bonanza, AbbVie, Sanofi Throw Billions at Stemcentrx, Medivation 04/28/16 San Francisco
Good Times Roll on for Biotech VCs As Clarus Bags New $500M Fund 06/09/15 Boston
Alexion Shells Out $8.4B for Synageva In Rare Disease Mega-Deal 05/06/15 Boston
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
West Coast Biotech Roundup: Juno, Nektar, Kite, Glooko & More 03/19/15 Seattle
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
West Coast Biotech Roundup: Pharmacyclics, Gates, Ikaria & More 03/05/15 San Francisco
AbbVie Snaps up Pharmacyclics, Pays Whopping $21B For Cancer Drug 03/05/15 National
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug 09/03/14 Boston
Gilead Edges Into Cancer Field With FDA OK of Calistoga Drug 07/23/14 San Francisco
Pharmacyclics, J&J Get FDA Nod for Chronic Lymphocytic Leukemia Drug 02/12/14 San Francisco
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
3 Life Sciences Companies That Are Built to Last 12/02/13 National
East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More 11/15/13 Boston
Pharmacyclics, J&J Win FDA Approval for Big Blood Cancer Drug 11/13/13 San Francisco
Gilead Climbs on More Good News for Cancer Drug From Seattle 10/10/13 Seattle
East Coast Life Sciences Roundup: Syndax, Enteris, Invivo, & More 08/30/13 Boston
Biotech VCs, Stung by Startup Returns, Elbow into Royalty Financing 08/16/13 Boston
East Coast Life Sciences Roundup: Dunsire, Good Start, Nimbus, & More 05/10/13 Boston
Former Keryx Exec’s Mission: Turn TG Into the Next Pharmacyclics 05/06/13 New York
Infinity Pharmaceuticals Bounces Back To Compete in Crowded Field 02/08/13 Boston
Page 1 of 2 next page »